Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oates

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.
Archives of Disease in Childhood|February 18, 2022
Rate and severity of radiological features of physical abuse in children during the first UK-wide COVID-19 enforced national lockdownStavros Stivaros, Michael Paddock, Azita Rajai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancerF Sclafani, G Brown, D Cunningham, et al.
Journal of the American Chemical Society|September 30, 2004
Ca(2.5)Sr(0.5)GaMn2O8: diamagnetic Ga in control of the structural and electronic properties of a bilayered manganatePeter D Battle, Stephen J Blundell, Michael L Brooks, et al.
Diabetes|June 29, 2006
Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damageEric C M Ho, Karen S L Lam, Yuk Shan Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2004
Central role for aldose reductase pathway in myocardial ischemic injuryYuying C Hwang, Michiyo Kaneko, Soliman Bakr, et al.
Science (New York, N.Y.)|May 16, 2009
Translational careersN Andrews, J E Burris, T R Cech, et al.
Open Journal of Epidemiology|January 18, 2021
Refining a Church-Based Lifestyle Intervention Targeting African-American Adults at Risk for Cardiometabolic Diseases: A Pilot StudyYuan E Zhou, Cynthia D Jackson, Veronica J Oates, et al.
Journal of Medicinal Chemistry|May 30, 2003
A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-oneBanavara L Mylari, Sandra J Armento, David A Beebe, et al.
Journal of Medicinal Chemistry|September 30, 2005
A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congenersBanavara L Mylari, Sandra J Armento, David A Beebe, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|July 2, 1999
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trialJ S Waters, A Norman, D Cunningham, et al.
Archives of Disease in Childhood|February 18, 2022
Rate and severity of radiological features of physical abuse in children during the first UK-wide COVID-19 enforced national lockdownStavros Stivaros, Michael Paddock, Azita Rajai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2016
PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancerF Sclafani, G Brown, D Cunningham, et al.
Journal of the American Chemical Society|September 30, 2004
Ca(2.5)Sr(0.5)GaMn2O8: diamagnetic Ga in control of the structural and electronic properties of a bilayered manganatePeter D Battle, Stephen J Blundell, Michael L Brooks, et al.
Diabetes|June 29, 2006
Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damageEric C M Ho, Karen S L Lam, Yuk Shan Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2004
Central role for aldose reductase pathway in myocardial ischemic injuryYuying C Hwang, Michiyo Kaneko, Soliman Bakr, et al.
Science (New York, N.Y.)|May 16, 2009
Translational careersN Andrews, J E Burris, T R Cech, et al.
Open Journal of Epidemiology|January 18, 2021
Refining a Church-Based Lifestyle Intervention Targeting African-American Adults at Risk for Cardiometabolic Diseases: A Pilot StudyYuan E Zhou, Cynthia D Jackson, Veronica J Oates, et al.
Journal of Medicinal Chemistry|May 30, 2003
A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-oneBanavara L Mylari, Sandra J Armento, David A Beebe, et al.
Journal of Medicinal Chemistry|September 30, 2005
A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congenersBanavara L Mylari, Sandra J Armento, David A Beebe, et al.
Pageof 24